The kynurenine system and immunoregulation

Journal of Neural Transmission

Volumn 119, Issue 2, 2012, Pages 197-209

  Mándi, Yvette ^a   Vécsei, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

IDO; Kynurenines; NK cells; T cells; TH1; TH2 cytokines; Treg cells

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 23; INTERLEUKIN 4; KYNURENIC ACID; KYNURENINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGING; CELL ACTIVATION; CELL FUNCTION; DEPRESSION; DRUG MECHANISM; GRANULOCYTE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; NATURAL KILLER CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SCHIZOPHRENIA; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; KYNURENINE; NEURAL PATHWAYS; T-LYMPHOCYTES, REGULATORY;

EID: 84857625769     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0681-y     Document Type: Review

References (121)

1. U Andersson HC Wang K Palmblad AC Aveberger O Bloom H Erlandsson-Harris A Janson R Kokkola MH Zhang H Yang KJ Tracey 2000 High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 565 570 10952726 1:CAS:528:DC%2BD3cXlvFemsL0%3D 10.1084/jem.192.4.565 (Pubitemid 30666257)
2. B Baban P Chandler D McCool B Marshall DH Munn AL Mellor 2004 Indoleamine 2, 3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific J Reprod Immunol 61 67 77 15063630 1:CAS:528:DC%2BD2cXivVWmtb0%3D 10.1016/j.jri.2003.11.003 (Pubitemid 38446980)
3. TA Babcock JM Carlin 2000 Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells Cytokine 12 588 594 10843733 1:CAS:528:DC%2BD3cXjvVSkt7o%3D 10.1006/cyto.1999.0661 (Pubitemid 30453486)
4. S Barry G Clarke P Scully TG Dinan 2009 Kynurenine pathway in psychosis: evidence of increased tryptophan degradation J Psychopharmacol 23 287 294 18562404 1:CAS:528:DC%2BD1MXmvVOqt74%3D 10.1177/0269881108089583
5. ML Belladonna P Puccetti C Orabona F Fallarino C Vacca C Volpi S Gizzi MT Pallotta MC Fioretti U Grohmann 2007 Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes Transplantation 84 S17 S20 17632406 1:CAS:528:DC%2BD2sXns1CmtLY%3D 10.1097/01.tp.0000269199.16209.22 (Pubitemid 47067536)
6. ML Belladonna C Volpi R Bianchi C Vacca C Orabona MT Pallotta L Boon S Gizzi MC Fioretti U Grohmann P Puccetti 2008 Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells J Immunol 181 5194 5198 18832670 1:CAS:528:DC%2BD1cXhtF2hs7jJ
7. ML Belladonna C Orabona U Grohmann P Puccetti 2009 TGF-beta and kynurenines as the key to infectious tolerance Trends Mol Med 15 41 49 19162548 1:CAS:528:DC%2BD1MXhvF2mtbY%3D 10.1016/j.molmed.2008.11.006
8. E Bettelli YJ Carrier WD Gao T Korn TB Strom M Oukka HL Weiner VK Kuchroo 2006 Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells Nature 441 235 238 16648838 1:CAS:528:DC%2BD28XksVGns7g%3D 10.1038/nature04753
9. GC Blobe WP Schiemann HF Lodish 2000 Mechanisms of disease: role of transforming growth factor beta in human disease N Engl J Med 342 1350 1358 10793168 1:CAS:528:DC%2BD3cXjtlyksrY%3D 10.1056/NEJM200005043421807 (Pubitemid 30408720)
10. S Bonaccorso V Marino M Biondi F Grimaldi F Ippoliti M Maes 2002 Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus J Affect Disord 72 237 241 12450640 1:CAS:528: DC%2BD38XovFGmu7w%3D 10.1016/S0165-0327(02)00264-1 (Pubitemid 35351283)
11. S Bozza F Fallarino L Pitzurra T Zelante C Montagnoli S Bellocchio P Mosci C Vacca P Puccetti L Romani 2005 A crucial role for tryptophan catabolism at the host/Candida albicans interface J Immunol 174 2910 2918 15728502 1:CAS:528:DC%2BD2MXhsFeqsbs%3D (Pubitemid 40279709)
12. JR Bradley 2008 TNF-mediated inflammatory disease J Pathol 214 149 160 18161752 1:CAS:528:DC%2BD1cXhvFCktrY%3D 10.1002/path.2287 (Pubitemid 351160153)
13. RR Brown CM Lee PC Kohler JA Hank BE Storer PM Sondel 1989 Altered tryptophan and neopterin metabolism in cancer-patients treated with recombinant interleukin-2 Cancer Res 49 4941 4944 2788032 1:STN:280:DyaL1Mzjs1OitA%3D%3D (Pubitemid 19213652)
14. ED Carosella P Moreau J Le Maoult M Le Discorde J Dausset N Rouas-Freiss 2003 HLA-G molecules: from maternal-fetal tolerance to tissue acceptance Adv Immunol 81 199 252 14711057 1:CAS:528:DC%2BD2cXhvFaqsrk%3D 10.1016/S0065- 2776(03)81006-4 (Pubitemid 38009044)
15. AC Chaves IP Cerávolo JA Gomes CL Zani AJ Romanha RT Gazzinelli 2001 IL-4 and IL-13 regulate the induction of indoleamine 2, 3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma Eur J Immunol 31 333 344 11180096 1:CAS:528: DC%2BD3MXhs1Kksrk%3D 10.1002/1521-4141(200102)31:2<333::AID-IMMU333>3.0. CO;2-X (Pubitemid 32166586)
16. Chomarat P, Rybak ME, Banchereau J (1998) Interleukin-4. In: Thomson A (ed) The cytokine handbook, 3rd edn. Academic Press, New York, pp 133-174
17. SY Chon HH Hassanain SL Gupta 1996 Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma- inducible expression of human indoleamine 2, 3-dioxygenase gene J Biol Chem 271 17247 17252 8663541 1:CAS:528:DyaK28XksFamt7w%3D 10.1074/jbc.271.29.17247 (Pubitemid 26244281)
18. IY Chung EN Benveniste 1990 Tumor necrosis factor-alpha production by astrocytes-induction by lipopolysaccharide, IFN-gamma, and IL-1-beta J Immunol 144 2999 3007 2109008 1:CAS:528:DyaK3cXitlektbY%3D (Pubitemid 20149471)
19. W Daubener CR MacKenzie 1999 IFN-gamma activated indoleamine 2, 3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism Adv Exp Med Biol 467 517 524 10721095 1:CAS:528: DC%2BD3cXis1ygtbc%3D 10.1007/978-1-4615-4709-9-64 (Pubitemid 32202197)
20. de Waal Malefyt, R, Moore KW (1998) Interleukin-10. In: Thomson A (ed) The cytokine handbook, 3rd edn. Academic Press, New York, pp 333-364
21. M Della Chiesa S Carlomagno G Frumento M Balsamo C Cantoni R Conte L Moretta A Moretta M Vitale 2006 The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell function Blood 108 4118 4125 16902152 1:CAS:528:DC%2BD28XhtlWqsrvF 10.1182/blood-2006-03-006700 (Pubitemid 44913283)
22. S Fallarini L Magliulo T Paoletti C de Lalla G Lombardi 2010 Expression of functional GPR35 in human iNKT cells Biochem Biophys Res Commun 398 420 425 20599711 1:CAS:528:DC%2BC3cXps1Ciu78%3D 10.1016/j.bbrc.2010.06.091
23. F Fallarino U Grohmann C Vacca R Bianchi C Orabona A Spreca MC Fioretti P Puccetti 2002 T cell apoptosis by tryptophan catabolism Cell Death Differ 9 1069 1077 12232795 1:CAS:528:DC%2BD38XmvFGhtbY%3D 10.1038/sj.cdd.4401073
24. F Fallarino U Grohmann S You BC McGrath DR Cavener C Vacca C Orabona R Bianchi ML Belladonna C Volpi P Santamaria MC Fioretti P Puccetti 2006 The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells J Immunol 176 6752 6761 16709834 1:CAS:528:DC%2BD28XkslWhsbs%3D (Pubitemid 43787857)
25. MC Fantini C Becker G Monteleone F Pallone PR Galle MF Neurath 2004 Cutting edge: TGF-beta induces a regulatory phenotype in CD4(+)CD25(-) T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 5149 5153 15100250 1:CAS:528:DC%2BD2cXjt1Cks7s%3D (Pubitemid 38542009)
26. W Fiers 1991 Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level FEBS Lett 285 199 212 1649771 1:CAS:528: DyaK3MXltFahtr4%3D 10.1016/0014-5793(91)80803-B
27. H Fillit W Ding L Buee J Kalman L Altstiel B Lawlor G Wolfklein 1991 Elevated circulating tumor-necrosis-factor levels in Alzheimers-disease Neurosci Lett 129 318 320 1745413 1:STN:280:DyaK38%2FotVWlsQ%3D%3D 10.1016/0304-3940(91) 90490-K
28. CM Forrest GM Mackay N Stoy SL Spiden R Taylor TW Stone LG Darlington 2010 Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease J Neurochem 112 112 122 19845828 1:CAS:528:DC%2BC3cXhs1GhsQ%3D%3D 10.1111/j.1471-4159.2009.06442.x
29. G Frumento R Rotondo M Tonetti G Damonte U Benatti GB Ferrara 2002 Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase J Exp Med 196 459 468 12186838 1:CAS:528:DC%2BD38XmsV2htLk%3D 10.1084/jem.20020121
30. H Fujigaki K Saito S Fujigaki M Takemura K Sudo H Ishiguro M Seishima 2006 The signal transducer and activator of transcription 1 alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2, 3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappa B pathways, and synergistic effect of several proinflammatory cytokines J Biochem 139 655 662 16672265 1:CAS:528:DC%2BD28XlsVGku7g%3D 10.1093/jb/mvj072 (Pubitemid 43973911)
31. EM Gal AD Sherman 1980 l-kynurenine-its synthesis and possible regulatory function in brain Neurochem Res 5 223 239 6154900 1:CAS:528:DyaL3cXhvFGisL4%3D 10.1007/BF00964611 (Pubitemid 10134133)
32. G Gigler G Szenasi A Simo G Levay LG Harsing K Sas L Vecsei J Toldi 2007 Neuroprotective effect of l-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils Eur J Pharmacol 564 116 122 17407777 1:CAS:528:DC%2BD2sXlt1Citro%3D 10.1016/j.ejphar.2007.02.029 (Pubitemid 46946855)
33. A Gonzalez N Varo E Alegre A Diaz I Melero 2008 Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach Adv Clin Chem 45 155 197 18429497 1:CAS:528:DC%2BD1cXmtF2is70%3D 10.1016/S0065-2423(07) 00007-8
34. A González-Hernandez J LeMaoult A Lopez E Alegre J Caumartin S Le Rond M Daouya P Moreau ED Carosella 2005 Linking two immuno-suppressive molecules: indoleamine 2, 3 dioxygenase can modify HLA-G cell-surface expression Biol Reprod 73 571 578 15878889 10.1095/biolreprod.105.040089 1:CAS:528:DC%2BD2MXovV2qtLY%3D (Pubitemid 41170213)
35. U Grohmann F Fallarino P Puccetti 2003 Tolerance, DCs and tryptophan: much ado about IDO Trends Immunol 24 242 248 12738417 1:CAS:528: DC%2BD3sXjsVartbk%3D 10.1016/S1471-4906(03)00072-3 (Pubitemid 36555962)
36. GJ Guillemin SJ Kerr GA Smythe DG Smith V Kapoor PJ Armati J Croitoru BJ Brew 2001 Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J Neurochem 78 842 853 11520905 1:CAS:528: DC%2BD3MXmt1egsLc%3D 10.1046/j.1471-4159.2001.00498.x (Pubitemid 32777985)
37. GJ Guillemin G Smythe O Takikawa BJ Brew 2005 Expression of indoleamine 2, 3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons Glia 49 15 23 15390107 10.1002/glia.20090 (Pubitemid 40023649)
38. Harber M, Sundstedt A, Wraith D (2000) The role of cytokines in immunological tolerance: potential for therapy. Exp Rev Mol Med 1-20
39. HE Harris U Andersson 2004 The nuclear protein HMGB1 as a proinflammatory mediator Eur J Immunol 34 1503 1512 10.1002/eji.200424916 1:CAS:528: DC%2BD2cXltFKrtbc%3D (Pubitemid 39256031)
40. Z Hartai P Klivenyi T Janaky B Penke L Dux L Vecsei 2005 Kynurenine metabolism in multiple sclerosis Acta Neurol Scand 112 93 96 16008534 1:CAS:528:DC%2BD2MXos1Crtbg%3D 10.1111/j.1600-0404.2005.00442.x (Pubitemid 41003368)
41. HH Hassanain SY Chon SL Gupta 1993 Differential regulation of human indoleamine 2, 3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor J Biol Chem 268 5077 5084 8444884 1:CAS:528:DyaK3sXhvV2kt7o%3D (Pubitemid 23081633)
42. M Hill S Tanguy-Royer P Royer C Chauveau K Asghar L Tesson F Lavainne S Remy R Brion FX Huber M Heslan M Rimbert L Berthelot JR Moffett R Josien M Gregoire I Anegon 2007 IDO expands human CD4(+)CD25(high) regulatory T cells by promoting maturation of LPS-treated dendritic cells Eur J Immunol 37 3054 3062 17948274 1:CAS:528:DC%2BD2sXhtl2qtr%2FE 10.1002/eji.200636704 (Pubitemid 350131285)
43. C Hilmas EF Pereira M Alkondon A Rassoulpour R Schwarcz EX Albuuqerque 2001 The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotic expression: physiopathological implications J Neurosci 21 7463 7473 11567036 1:CAS:528:DC%2BD3MXnsFCksrc%3D (Pubitemid 32904945)
44. J Kaszaki Z Palasthy D Erczes A Racz C Torday G Varga L Vecsei M Boros 2008 Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs Neurogastroenterol Motil 20 53 62 17973632 1:CAS:528:DC%2BD1cXisFGjs7g%3D (Pubitemid 350277448)
45. T Kita PF Morrison MP Heyes SP Markey 2002 Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the l-kynurenine and quinolinic acid pools in brain J Neurochem 82 258 268 12124427 1:CAS:528:DC%2BD38XlslKmsbc%3D 10.1046/j.1471-4159.2002.00955. x (Pubitemid 34774617)
46. Klivenyi P, Toldi J, Vecsei L (2004) Kynurenines in neurodegenerative disorders: therapeutic consideration. In: Vecsei L (ed) Frontiers in clinical neuroscience: neurodegeneration and neuroprotection, Adv Exp Med Biol, vol 541, Kluwer, New York, pp 169-183
47. AK Kocsis A Szabolcs P Hofner T Takács G Farkas K Boda Y Mándi 2009 Plasma concentrations of high-mobility group box protein1, soluble receptor for advanced glycation end products and circulating DNA in patients with acute pancreatitis Pancreatology 9 383 391 19451748 1:CAS:528:DC%2BD1MXntFartbk%3D 10.1159/000181172
48. M Kronenberg 2005 Toward an understanding of NKT cell biology: progress and paradoxes Annu Rev Immunol 23 877 900 15771592 1:CAS:528: DC%2BD2MXktFOju7k%3D 10.1146/annurev.immunol.23.021704.115742 (Pubitemid 40563188)
49. Y Kudo CAR Boyd IL Sargent CWG Redman 2003 Decreased tryptophan catabolism by placental indoleamine 2, 3-dioxygenase in preeclampsia Am J Obstet Gynecol 188 719 726 12634647 1:CAS:528:DC%2BD3sXisValtbg%3D 10.1067/mob.2003.156 (Pubitemid 36332440)
50. Y Kudo CAR Boyd I Spyropoulou CWG Redman O Takikawa T Katsuki T Hara K Ohama IL Sargent 2004 Indoleamine 2, 3-dioxygenase: distribution and function in the developing human placenta J Reprod Immunol 61 87 98 15063632 1:CAS:528:DC%2BD2cXivVWmtbs%3D 10.1016/j.jri.2003.11.004 (Pubitemid 38446982)
51. RM Leonhardt SJ Lee PB Kavathas P Cresswell 2007 Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis Infect Immun 75 5105 5117 17724071 1:CAS:528: DC%2BD2sXht1CrtLzI 10.1128/IAI.00668-07 (Pubitemid 350033597)
52. RM Levy KP Mollen JM Prince DJ Kaczorowski R Vallabhaneni S Liu KJ Tracey MT Lotze DJ Hackam MP Fink Y Vodovotz TR Billiar 2007 Systemic inflammation and remote organ injury following trauma require HMGB1 Am J Physiol Regul Integr Comp Physiol 293 R1538 R1544 17652366 1:CAS:528:DC%2BD2sXht1Wlu73M 10.1152/ajpregu.00272.2007 (Pubitemid 47535772)
53. MO Li YY Wan S Sanjabi AKL Robertson RA Flavell 2006 Transforming growth factor-beta regulation of immune responses Annu Rev Immunol 24 99 146 16551245 1:CAS:528:DC%2BD28XkvFSqt7w%3D 10.1146/annurev.immunol.24.021605.090737
54. D Lio L Scola A Crivello M Bonafe C Franceschi F Olivieri G Colonna-Romano G Candore C Caruso 2002 Allele frequencies of +874T->a single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians Exp Gerontol 37 315 319 11772518 1:CAS:528: DC%2BD38XitlGl 10.1016/S0531-5565(01)00198-X (Pubitemid 34073549)
55. TT Lögters MD Laryea J Altrichter J Sokolowski J Cinatl J Reipen W Linhart J Windolf M Scholz M Wild 2009 Increased plasma kynurenine values and kynurenine-tryptophan ratios after major trauma are early indicators for the development of sepsis Shock 32 29 34 19060785 10.1097/SHK.0b013e31819714fa 1:CAS:528:DC%2BD1MXnsVegur4%3D
56. AS Lopez E Alegre J LeMaoult E Carosella A Gonzalez 2006 Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells Mol Immunol 43 2151 2160 16490253 1:CAS:528:DC%2BD28XlsFCns7s%3D 10.1016/j.molimm.2006.01.007 (Pubitemid 43831200)
57. MT Lotze KJ Tracey 2005 High-mobility group box 1 protein (HMGB): nuclear weapon in the immune arsenal Nat Rev Immunol 5 331 342 15803152 1:CAS:528:DC%2BD2MXivVarsr8%3D 10.1038/nri1594 (Pubitemid 40516158)
58. M Maes L Mihaylova M De Ruyter M Kubera E Bosmans 2007 The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression and other conditions characterized by tryptophan depletion induced by inflammation Neuro Endocrinol Lett 28 826 831 18063923 1:CAS:528: DC%2BD1cXht1eju7c%3D
59. J Mazza A Rossi JM Weinberg 2010 Innovatives uses of tumor necrosis factor alpha inhibitors Dermatol Clin 28 559 575 20510765 1:CAS:528: DC%2BC3cXosFeru7c%3D 10.1016/j.det.2010.03.009
60. D McIlroy S Tanguy-Royer N Le Meur I Guisle PJ Royer J Leger K Meflah M Gregoire 2005 Profiling dendritic cell maturation with dedicated microarrays J Leukoc Biol 78 794 803 15961579 1:CAS:528:DC%2BD2MXhtVSksbrL 10.1189/jlb.0105029 (Pubitemid 41292103)
61. AL Mellor DH Munn 2004 IDO expression by dendritic cells: tolerance and tryptophan catabolism Nature Rev Immunol 4 762 774 1:CAS:528: DC%2BD2cXotVSlsLg%3D 10.1038/nri1457 (Pubitemid 39336293)
62. CL Miller IC Llenos M Cwik J Walkup S Weis 2008 Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder Neurochem Int 52 1297 1303 18328600 1:CAS:528:DC%2BD1cXktVKltLs%3D 10.1016/j.neuint.2008. 01.013
63. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198-209 (Pubitemid 351874183)
64. JR Moffett MA Namboodiri 2003 Tryptophan and the immune response Immunol Cell Biol 81 247 265 12848846 1:CAS:528:DC%2BD3sXmvFSmtLw%3D 10.1046/j.1440-1711.2003.t01-1-01177.x (Pubitemid 36904332)
65. A Molano P Illarionov GS Besra C Putterman SA Porcelli 2008 Modulation of invariant natural killer T cell cytokine responses by indoleamine 2, 3-dioxygenase Immunol Lett 117 81 90 18272236 1:CAS:528:DC%2BD1cXjtlWgtr0%3D 10.1016/j.imlet.2007.12.013
66. N Müller M Schwarz 2006 Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission Neurotox Res 10 131 148 17062375 10.1007/BF03033242
67. N Müller MJ Schwarz 2007 The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view J Neural Transm Suppl 72 269 280 10.1007/978-3-211-73574-9-33
68. N Müller MJ Schwarz 2010 Immune system and schizophrenia Curr Immunol Rev 6 213 220 21057585 10.2174/157339510791823673
69. N Müller AM Myint MJ Schwarz 2011 Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects Curr Pharm Res 17 130 136 10.2174/138161211795049552
70. DH Munn M Zhou JT Attwood I Bondarev SJ Conway B Marshall C Brown AL Mellor 1998 Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1191 1193 9712583 1:CAS:528:DyaK1cXls1Cqu7c%3D 10.1126/science.281. 5380.1191 (Pubitemid 28406294)
71. T Musso GL Gusella A Brooks DL Longo L Varesio 1994 Interleukin-4 inhibits indoleamine 2, 3-dioxygenase expression in human monocytes Blood 83 1408 1411 8118042 1:CAS:528:DyaK2cXitFCqtL0%3D (Pubitemid 24062865)
72. AM Myint YK Kim 2003 Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression Med Hypotheses 61 519 525 14592780 1:CAS:528:DC%2BD3sXosVynsbs%3D 10.1016/S0306-9877(03)00207-X (Pubitemid 37411894)
73. H Nemeth J Toldi L Vecsei 2005 Role of kynurenines in the central and peripherial nervous systems Curr Neurovasc Res 2 249 260 16181118 10.2174/1567202054368326 (Pubitemid 40980183)
74. JC O'Connor C Andre YX Wang MA Lawson SS Szegedi J Lestage N Castanon KW Kelley R Dantzer 2009 Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus calmette-guerin J Neurosci 29 4200 4209 19339614 10.1523/JNEUROSCI.5032-08.2009 1:CAS:528:DC%2BD1MXktlaktb8%3D
75. GF Oxenkrug 2007 Genetic and hormonal regulation of tryptophan-kynurenine metabolism-implications for vascular cognitive Impairment, major depressive disorder, and aging Ann NY Acad Sci 1122 35 49 18077563 1:CAS:528: DC%2BD1cXhtVOks7c%3D 10.1196/annals.1403.003 (Pubitemid 350249540)
76. GF Oxenkrug 2010 Tryptophan-kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later Israel J Psychiatry 47 56 63
77. GF Oxenkrug 2011 Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders J Neural Transm 118 75 85 20811799 1:CAS:528: DC%2BC3MXhtFSjsrs%3D 10.1007/s00702-010-0475-7
78. LA Pemberton SJ Kerr G Smythe BJ Brew 1997 Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha J Interferon Cytokine Res 17 589 595 9355959 1:CAS:528:DyaK2sXmslGks7g%3D 10.1089/jir.1997.17.589 (Pubitemid 27451155)
79. DS Pisetsky H Erlandsson-Harris U Andersson 2008 High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease Arthritis Res Ther 10 209 18598385 10.1186/ar2440 1:CAS:528:DC%2BD1cXpvF2ktLc%3D
80. V Pravica C Perrey A Stevens JH Lee IV Hutchinson 2000 A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production Hum Immunol 61 863 866 11053629 1:CAS:528: DC%2BD3cXosVWlu7s%3D 10.1016/S0198-8859(00)00167-1
81. P Puccetti U Grohmann 2007 IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappa B activation Nat Rev Immunol 7 817 823 17767193 1:CAS:528:DC%2BD2sXhtVOrtbnN 10.1038/nri2163 (Pubitemid 47480306)
82. K Quinn M Henriques T Parker AS Slutsky H Zhang 2008 Human neutrophil peptides: a novel potential mediator of inflammatory Am J Physiol Heart Circ Physiol 295 1817 1824 10.1152/ajpheart.00472.2008 1:CAS:528:DC%2BD1cXhsVWktb7F
83. CL Raison R Dantzer KW Kelley MA Lawson BJ Woolwine G Vogt JR Spivey K Saito AH Miller 2010 CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression Mol Psychiatry 15 393 403 19918244 1:CAS:528:DC%2BC3cXjslWitr8%3D 10.1038/mp.2009.116
84. A Raitala M Pertovaara J Karjalainen SS Oja M Hurme 2005 Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals Scand J Immunol 61 387 390 15853924 1:CAS:528:DC%2BD2MXht1Witb3K 10.1111/j.1365-3083.2005.01586.x (Pubitemid 40637846)
85. M Riedel I Spellmann MJ Schwarz M Strassnig C Sikorski HJ Moller N Muller 2007 Decreased T cellular immune response in schizophrenic patients J Psychiatr Res 41 3 7 16434055 10.1016/j.jpsychires.2005.11.007 (Pubitemid 44708207)
86. CM Robinson PT Hale JM Carlin 2005 The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase J Interferon Cytokine Res 25 20 30 15684619 1:CAS:528:DC%2BD2MXit1Gntw%3D%3D 10.1089/jir.2005.25.20 (Pubitemid 40105588)
87. H Robotka J Toldi L Vécsei 2008 l-kynurenine: metabolism and mechanism of neuroprotection Future Neurol 3 169 188 1:CAS:528: DC%2BD1cXis1Whsrc%3D 10.2217/14796708.3.2.169 (Pubitemid 351385961)
88. S Romagnani 1999 Th1/Th2 cells Inflamm Bowel Dis 5 285 294 10579123 1:STN:280:DC%2BD3c%2Fks1Srtw%3D%3D 10.1002/ibd.3780050410
89. N RouasFreiss RMB Goncalves C Menier J Dausset ED Carosella 1997 Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis Proc Natl Acad Sci USA 94 11520 11525 1:CAS:528:DyaK2sXmslaqsrk%3D 10.1073/pnas.94.21.11520 (Pubitemid 27451031)
90. YP Rubtsov AY Rudensky 2007 TGF beta signalling in control of T-cell-mediated self-reactivity Nat Rev Immunol 7 443 453 17525753 1:CAS:528:DC%2BD2sXls1Kgt78%3D 10.1038/nri2095 (Pubitemid 46834850)
91. SA Sarkar R Wong SI Hackl O Moua RG Gill A Wiseman HW Davidson JC Hutton 2007 Induction of indoleamine 2, 3-dioxygenase by interferon-gamma in human islets Diabetes 56 72 79 17192467 1:CAS:528:DC%2BD2sXhtVWltr0%3D 10.2337/db06-0617
92. K Sas H Robotka J Toldi L Vecsei 2007 Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders J Neurol Sci 257 221 239 17462670 1:CAS:528:DC%2BD2sXmtlWgurw%3D 10.1016/j.jns.2007.01.033 (Pubitemid 46856508)
93. R Schwarcz R Pellicciari 2002 Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J Pharmacol Exp Ther 303 1 10 12235226 1:CAS:528:DC%2BD38XnsV2ru7k%3D 10.1124/jpet.102.034439
94. R Schwarcz WO Whetsell RM Mangano 1983 Quinolinic acid-an endogenous metabolite that produces axon-sparing lesions in rat-brain Science 219 316 318 6849138 1:CAS:528:DyaL3sXmvF2gsQ%3D%3D 10.1126/science.6849138 (Pubitemid 13222319)
95. Song H, Park H, Kim Y-S, Kim KD, Lee H-K, Cho D-H, Yang J-W, Hur DY (2011) l-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species. Int Immunopharmacol. doi: 10.1016/j.intimp.2011.02.005
96. NK Steckel M Koldehoff DW Beelen AH Elmaagacli 2005 Indoleamine 2, 3-dioxygenase expression in monocytes of healthy nonpregnant women after induction with human choriongonadotropine Scand J Immunol 61 213 214 15683459 1:CAS:528:DC%2BD2MXitFOisr0%3D 10.1111/j.0300-9475.2005.01538.x (Pubitemid 40255366)
97. TW Stone 1993 Neuropharmacology of quinolinic and kynurenic acids Pharmacol Rev 45 309 379 8248282 1:CAS:528:DyaK3sXmtFKltr8%3D (Pubitemid 23292874)
98. TW Stone 2000 Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection Trends Pharmacol Sci 21 149 154 10740291 1:CAS:528:DC%2BD3cXisFGgsL0%3D 10.1016/S0165-6147(00)01451-6 (Pubitemid 30190140)
99. TW Stone 2001 Kynurenines in the CNS: from endogenous obscurity to therapeutic importance Progr Neurobiol 64 185 218 1:CAS:528:DC%2BD3MXhs1aqsbY%3D 10.1016/S0301-0082(00)00032-0 (Pubitemid 32195412)
100. TW Stone 2007 Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats Eur J Neurosci 25 2656 2665 17459105 10.1111/j.1460-9568.2007.05540.x (Pubitemid 46888851)
101. TW Stone LG Darlington 2002 Endogenous kynurenines as targets for drug discovery and development Nat Rev Drug Discov 1 609 620 12402501 1:CAS:528:DC%2BD38XlslGqtr4%3D 10.1038/nrd870 (Pubitemid 37361524)
102. TW Stone MN Perkins 1981 Quinolinic acid-a potent endogenous excitant at amino-acid receptors in CNS Eur J Pharmacol 72 411 412 6268428 1:CAS:528:DyaL3MXlsVChs7Y%3D 10.1016/0014-2999(81)90587-2 (Pubitemid 11081065)
103. J Sundén-Cullberg A Norrby-Teglund CJ Treutiger 2006 The role of high mobility group box-1 protein in severe sepsis Curr Opin Infect Dis 19 231 236 16645483 10.1097/01.qco.0000224816.96986.67 1:CAS:528:DC%2BD28XjvFKltL0%3D (Pubitemid 43740360)
104. KJ Swartz MJ During A Freese MF Beal 1990 Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors J Neurosci 10 2965 2973 2168940 1:CAS:528:DyaK3cXmt1Cru7c%3D
105. P Terness TM Bauer L Rose C Dufter A Watzlik H Simon G Opelz 2002 Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites J Exp Med 196 447 457 12186837 1:CAS:528:DC%2BD38XmsV2htLg%3D 10.1084/jem.20020052
106. Tiszlavicz Z, Németh B, Fülöp F, Vécsei L, Tápai K, Ocsovszky I, Mándi Y. (2011) Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils. Naunyn Schmiedebergs Arch Pharmacol. doi: 10.1007/s00210-011-0605-2
107. G Trinchieri 1989 Biology of natural-killer cells Adv Immunol 47 187 376 2683611 1:STN:280:DyaK3c%2Flt1yrsw%3D%3D 10.1016/S0065-2776(08)60664-1
108. AR Van Gool R Verkerk D Fekkes M Bannink S Sleijfer WHJ Kruit B van der Holt S Scharpe AMM Eggermont G Stoter MW Hengeveld 2008 Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status Psychiatry Clin Neurosci 62 597 602 18950381 10.1111/j.1440-1819.2008.01854.x 1:CAS:528:DC%2BD1cXhsVeqsL%2FL
109. L Vecsei MF Beal 1991 Comparative behavioral and neurochemical studies with striatal kainic acid-lesioned or quinolinic acid-lesioned rats Pharmacol Biochem Behav 39 473 478 1719569 1:CAS:528:DyaK3MXltlegsLc%3D 10.1016/0091-3057(91)90211-J
110. L Vecsei J Miller U MacGarvey MF Beal 1992 Kynurenine and probenecid inhibit pentylenetetrazol-induced and NMDA-induced seizures and increase kynurenic acid concentrations in the brain Brain Res Bull 28 233 238 1596743 1:CAS:528:DyaK38XhsVeksLk%3D 10.1016/0361-9230(92)90184-Y
111. I Waldhauer A Steinle 2008 NK cells and cancer immunosurveillance Oncogene 27 5932 5943 18836474 1:CAS:528:DC%2BD1cXhtF2msbnE 10.1038/onc.2008.267
112. JH Wang N Simonavicius XS Wu G Swaminath J Reagan H Tian L Ling 2006 Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J Biol Chem 281 22021 22028 16754668 1:CAS:528:DC%2BD28XnsVOmsbo%3D 10.1074/jbc.M603503200 (Pubitemid 44181906)
113. MC Wichers M Maes 2004 The role of indoleamine 2, 3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression J Psychiatry Neurosci 29 11 17 14719046 (Pubitemid 38570008)
114. B Wirleitner G Neurauter K Schrocksnadel B Frick D Fuchs 2003 Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects Curr Med Chem 10 1581 1591 12871129 1:CAS:528:DC%2BD3sXls1Wru74%3D 10.2174/0929867033457179 (Pubitemid 36896559)
115. L Wu CL Gabriel VV Parekh L Van Kaer 2009 Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities Tissue Antigens 73 535 545 19392798 1:CAS:528:DC%2BD1MXmvVWisL0%3D 10.1111/j.1399-0039. 2009.01256.x
116. H Xu G-X Zhang B Ciric A Rostami 2008 IDO: a double-edged sword for T(H)1/T(H)2 regulation Immunol Lett 121 1 6 18824197 1:CAS:528: DC%2BD1cXht12lsbbK 10.1016/j.imlet.2008.08.008
117. MC Yadav EM Burudi M Alirezaei CC Flynn DD Watry CM Lanigan HS Fox 2007 IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4 Glia 55 1385 1396 17661345 10.1002/glia.20544 (Pubitemid 47328941)
118. T Yamamura K Sakuishi Z Illes S Miyake 2007 Understanding the behavior of invariant NKT cells in autoimmune diseases J Neuroimmunol 191 8 15 17905445 1:CAS:528:DC%2BD2sXht12nsrnF 10.1016/j.jneuroim.2007.09.014 (Pubitemid 350060994)
119. D Yang A Biragyn LW Kwak JJ Oppenheim 2002 Mammalian defensins in immunity: more than just microbicidal Trends Immunol 23 291 296 12072367 1:CAS:528:DC%2BD38XksF2hu7s%3D 10.1016/S1471-4906(02)02246-9 (Pubitemid 34628771)
120. D Zádori P Klivényi E Vámos F Fülöp J Toldi L Vécsei 2009 Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies J Neural Transm 116 1403 1409 19618107 10.1007/s00702-009-0263-4 1:CAS:528:DC%2BD1MXhtlKhsbzL
121. JY Zou FT Crews 2005 TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition Brain Res 1034 11 24 15713255 1:CAS:528: DC%2BD2MXhtlSmtLw%3D 10.1016/j.brainres.2004.11.014 (Pubitemid 40248516)